Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients
2011
Purpose
The purpose of this study was to evaluate the risk factors associated with the treatment failure and 30-day mortality in hematology and bone marrow transplant patients treated with daptomycin or linezolid for vancomycin-resistant enterococci (VRE) bacteremia. The safety and tolerability of therapy was also assessed.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
18
References
40
Citations
NaN
KQI